Adiponectin also exhibits anti-hyperglycemic, anti-atherogenic, and anti-inflammatory properties, and could have important clinical benefits in terms of development of therapies for the prevention and/or the treatment of obesity, and obesity-related diseases [49]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.